The influence of hormone replacement therapy on the pathology of breast cancer

European Journal of Surgical Oncology

Volumn 31, Issue 5, 2005, Pages 467-472

  Biglia, N ^a   Sgro, L ^a   Defabiani, E ^a   De Rosa, G ^b   Ponzone, R ^a   Marenco, D ^a   Sismondi, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

Breast cancer; Hormone replacement therapy; Pathology

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53; PROTEIN PS2; SEX HORMONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CARCINOMA IN SITU; CLINICAL FEATURE; CONTROLLED STUDY; DRUG USE; FEMALE; FREQUENCY ANALYSIS; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

AGED; BREAST NEOPLASMS; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSTMENOPAUSE; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 19444382612     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.02.005     Document Type: Article

References (36)

1. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 10,8411 women without breast cancer Lancet 350 1997 1047-1059
2. J.E. Rossouw G.L. Anderson R.L. Prentice A.Z. LaCroix C. Kooperberg M.L. Stefanick et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321-333
3. Million Women Study Collaborators Breast cancer and hormone replacement therapy in the Million Women Study Lancet 362 2003 419-427
4. The Women's Health Steering Committee Effects of conjugated equine estrogen in postmenopausal women with hysterectomy JAMA 291 2004 1701-1712
5. B.F. Byrd Jr J.C. Burch W.K. Vaughn The impact of long term estrogen support after hysterectomy. A report of 1067 cases Ann Surg 185 1977 574-580
6. K. Nanda L.A. Bastian K. Schulz Hormone replacement therapy and the risk of death from breast cancer: A systematic review Am J Obstet Gynaecol 186 2002 325-334
7. R.T. Chlebowski S.L. Hendrix R.D. Langer M.L. Stefanick M. Gass D. Lane et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women JAMA 289 2003 3243-3253
8. F.A. Tavassoli P. Devilee Pathology and genetics of tumors of the breast and female genital organs. World Health Organization classification of tumors 2003 IARC Press (International Agency for Research on Cancer) Lyon
9. C.W. Elston C. Ellis Pathological prognostic factors in breast cancer. I. The value of histological breast cancer: Experience from a large study with long term follow-up Histopatology 19 1991 403-410
10. B. Thuerlimann International consensus meeting on the treatment of primary breast cancer 2001, St Gallen, Switzerland Breast Cancer 8 2001 294-297
11. A.E. Pinto S. Andrè T. Pereira S. Nòbrega J. Soares Prognostic comparative study of S-phase fraction and Ki-67 index in breast cancer J Clin Pathol 54 2001 543-549
12. C. Schairer M. Gail C. Byrne P.S. Rosenberg S.R. Sturgeon L.A. Brinton Hormone replacement therapy and breast cancer survival in a large screening study J Natl Cancer Inst 91 1999 264-270
13. M.M. Bilimoria D.J. Winchester S.F. Sener G. Motykie U.L. Sehgal D.P. Winchester Estrogen replacement therapy and breast cancer: Analysis of age of onset and tumor characteristics Ann Surg Oncol 6 1999 200-207
14. B. Fowble A. Hanlon G. Freedman A. Patchefsky H. Kessler N. Nicolaou et al. Postmenopausal hormone replacement therapy: Effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation J Clin Oncol 17 1999 1680-1688
15. C. Gajdos P.I. Tartter A. Babinszki Breast cancer diagnosed during hormone replacement therapy Obstet Gynaecol 95 2000 513-518
16. C. Jones D. Ingram E. Mattes R. Hahnel The effect of hormone replacement therapy on prognostic indices in women with breast cancer Med J Aust 161 1994 106-110
17. C. Magnusson L. Holmberg T. Norden A. Lindgren I. Persson Prognostic characteristics in breast cancers after hormone replacement therapy Breast Cancer Res Treat 38 1996 325-334
18. P. Bonnier F. Bessenay A.J. Sasco B. Beedassy C. Lejeune S. Romain et al. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer Int J Cancer 79 1998 278-282
19. I.F. O'Connor M.V. Shembekar S. Shousha Breast carcinoma developing in patients on hormone replacement therapy: A histological and immunohistological study J Clin Pathol 51 1998 935-938
20. K. Holli J. Isola J. Cuzick Low biologic aggressiveness in breast cancer in women using hormone replacement therapy J Clin Oncol 16 1998 3115-3120
21. R.J. Salmon Y. Ansquer B. Asselain O. Languille G. Lesec Y. Remvikos Characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause Oncol Rep 6 1999 699-703
22. J. Manjer J. Malina G.L. Berglund Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy Int J Cancer 92 2001 919-922
23. J. Cheek J. Lacy S. Toth-Fejel K. Morris K. Calhoun R.F. Pormnier The impact of hormone replacement therapy on the detection and stage of breast cancer Arch Surg 137 2002 1015-1019 discussion 1019-21
24. V. Sacchini S. Zurrida G. Andreoni A. Luini V. Galimberti P. Veronesi et al. Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users Ann Surg Oncol 9 2002 266-271
25. C. Harding W.F. Knox E.B. Faragher A. Baildam N.J. Bundred Hormone replacement therapy and tumor grade in breast cancer: Prospective study in screening unit BMJ 313 1996 198
26. S. Stallard J.C. Litherland C.M. Cordiner H.M. Dobson W.D. George E.A. Mallon et al. Effect of hormone replacement therapy on the pathological stage of breast cancer: Population based, cross sectional study BMJ 320 2000 348-349
27. C.I. Li N.S. Weiss J.L. Stanford J.R. Daling Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women Cancer 88 2000 2570-2577
28. L.M. Newcomer P.A. Newcomb J.D. Potter Y. Yasui A. Trentham-Dietz B.E. Storer et al. Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States) Cancer Causes Control 3 2003 225-233
29. C.L. Chen N.S. Weiss P. Newcomb W. Barlow E. White Hormone replacement therapy in relation to breast cancer JAMA 287 2002 734-741
30. P.A. Newcomb L. Titus-Ernstoff K.M. Egan A. Trentham-Dietz J.A. Baron B.E. Storer et al. Postmenopausal estrogen and progestin use in relation to breast cancer risk Cancer Epidemiol Biomarkers Prev 11 2002 593-600
31. J.R. Daling K.E. Malone D.R. Doody L.F. Voigt L. Bemstein R.J. Coates et al. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma Cancer 95 2002 2455-2464
32. C.I. Li K.E.Z. Malone P.L. Porter N.S. Weiss M.T. Tang K.L. Cushing-Haugen et al. Relationship between long durations and different regimens of hormone replacement therapy and risk of cancer JAMA 289 2003 3254-3263
33. C.I. Li B.O. Anderson J.R. Daling R.E. Moe Trends in incidence rates of invasive lobular and ductal breast carcinoma JAMA 289 2003 1421-1424
34. R.C. Delgado D.M. Lubian Lopez Prognosis of breast cancers detected in women receiving hormone replacement therapy Maturitas 38 2001 147-156
35. D.M. Strickland R.D. Gambrell Jr C.A. Butzin K. Strickland The relationship between breast cancer survival and prior postmenopausal estrogen use Obstet Gynaecol 80 1992 400-404
36. R. Squitieri P.I. Tartter S. Ahmed S.T. Brower N.D. Theise Carcinoma of the breast in postmenopausal hormone user and nonuser control groups J Am Coll Surg 178 1994 167-170